High FCRL5 expression predicts poor treatment response and survival in newly diagnosed multiple myeloma: a retrospective study
-
By
-
Cainan Yu
-
Minghua Zhang
-
Jie Hui
-
Mengqing Zhu
-
Zengtian Sun
-
Yueyue Sun
-
Qian Sun
-
Zhiling Yan
-
Feng Zhu
-
Mingshan Niu
-
Depeng Li
-
Kunming Qi
-
June 29, 2026
-
0 min
Top Institutions in Oncology
Brief introduction explaining scope and methodology.
-
#1
Mayo Clinic
Rochester, Minnesota
-
#2
Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu
-
#3
Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM)
Florence, Italy
-
#4
University Hospitals Cleveland Medical Center
Cleveland, Ohio
-
#5
University of Cincinnati
Cincinnati, Ohio
